BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Early pregnancy factor
,
Doxycycline
,
rs7903146
,
ERBB2
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
n- myc protein
Summary
General Info
Curated Studies
Most Correlated Studies
Treatment of induce pluripotent stem cells with LIF and/or bFG
Epiblast stem cell-like iPS cells reprogrammed under specific culturing conditions
iPSCs from adult adipose stem cells using minicircle reprogramming vectors compared to other methods
Molecular insights into induced pluripotency: a time course
Neuroblastoma SHEP cells with dox-induced/uninduced MYCN before or after nutlin-3a treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting protein folding in N-Myc-driven medulloblastoma.
MYCN protein stability is a better prognostic indicator in neuroblastoma.
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma.
Function of Oncogene Mycn in Adult Neurogenesis and Oligodendrogenesis.
Mycn deficiency underlies the development of orofacial clefts in mice and humans.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Re…
A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcript…
SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL W…
Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Di…
Mycoprotein and Muscle Protein Synthetic Response
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ